Method for thrombogenicity testing of implanted medical device
US-9193987-B2 · Nov 24, 2015 · US
Method of determining 1,5-anhydroglucitol, and reagent composition for determining 1,5-anhydroglucitol
US8945864B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8945864-B2 |
| Application number | US-30594107-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 22, 2007 |
| Priority date | Jun 22, 2006 |
| Publication date | Feb 3, 2015 |
| Grant date | Feb 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The object of the present invention is to provide a method of determining 1,5-anhydroglucitol, including using (a) a protein which consists of the amino acid sequence of SEQ ID NO: 2; (b) a protein which consists of an amino acid sequence having deletion, substitution and/or addition of one or more amino acid residues in the amino acid sequence of SEQ ID NO: 2 and which has sorbose dehydrogenase activity; or (c) a protein which consists of an amino acid sequence having a homology of at least 60% with the amino acid sequence of SEQ ID NO: 2 and which has sorbose dehydrogenase activity.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method of determining a quantity of 1,5-anhydroglucitol in a sample, comprising using (a) a recombinant protein which consists of amino acid sequence SEQ ID NO: 2; or (b) a recombinant protein which consists of amino acid sequence having a homology of at least 85% with the amino acid sequence SEQ ID NO: 2 and which has sorbose dehydrogenase activity. 2. The method of determining 1,5-anhydroglucitol according to claim 1 , wher…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Physics · mapped topic
- C12Q1/32Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8945864B2 cover?
- The object of the present invention is to provide a method of determining 1,5-anhydroglucitol, including using (a) a protein which consists of the amino acid sequence of SEQ ID NO: 2; (b) a protein which consists of an amino acid sequence having deletion, substitution and/or addition of one or more amino acid residues in the amino acid sequence of SEQ ID NO: 2 and which has sorbose dehydrogenas…
- Who is the assignee on this patent?
- Ishimaru Emi, Sanada Hirokazu, Omura Hironori, and 5 more
- What technology area does this patent fall under?
- Primary CPC classification C12Q1/32. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).